Literature DB >> 9215367

Changes in otoacoustic emissions and auditory brain stem response after cis-platinum exposure in gerbils.

K C Sie1, S J Norton.   

Abstract

Ototoxicity associated with cis-platinum administration commonly presents as hearing loss and tinnitus. The hearing loss is usually an irreversible, high-frequency sensorineural loss. Histologic studies in humans and animals suggest that the outer hair cells (OHCs) are most susceptible to cis-platinum. Evoked otoacoustic emissions (EOAE), as a measure of outer hair cell function, are potentially useful in following ototoxic insults involving OHCs. Distortion-product otoacoustic emissions (DPOAE) test frequency-specific regions of the cochlea and therefore may be particularly well suited for monitoring ototoxic injuries. We measured distortion product otoacoustic emissions, at f2 = 2, 4, 6, 8, 10, and 12 kHz, in gerbils after a single large dose of cis-platinum. Animals treated with saline served as controls. The findings were compared to auditory brain stem evoked response (ABR) thresholds, using tone pips of the same frequencies. The DPOAE and ABR thresholds were measured before treatment and again 2, 5, and 14 days after drug administration. The changes in DPOAE were compared with the changes in ABR. No treatment effect was noted in the 2-day group. Animals treated with cis-platinum demonstrated significant elevation of DPOAE and ABR thresholds compared with control animals at 5 and 14 days. There was no significant difference between the threshold changes in the 5- and 14-day groups.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9215367     DOI: 10.1016/S0194-59989770232-8

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  4 in total

1.  Effects of hyperbaric oxygen treatment on auditory hair cells after acute noise damage.

Authors:  Gleice Cristina Colombari; Maria Rossato; Omar Feres; Miguel Angelo Hyppolito
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-07-21       Impact factor: 2.503

2.  Cisplatin ototoxicity and otoprotection with sodium salicylate.

Authors:  Miguel Angelo Hyppolito; José Antonio A de Oliveira; Maria Rossato
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-06-07       Impact factor: 2.503

3.  Temporary reduction of distortion product otoacoustic emissions (DPOAEs) immediately following auditory brainstem response (ABR).

Authors:  Anand N Mhatre; Bobby Tajudeen; Elena M Welt; Christopher Wartmann; Glenis R Long; Anil K Lalwani
Journal:  Hear Res       Date:  2010-06-25       Impact factor: 3.208

4.  Proposed comprehensive ototoxicity monitoring program for VA healthcare (COMP-VA).

Authors:  Dawn Konrad-Martin; Kelly M Reavis; Garnett McMillan; Wendy J Helt; Marilyn Dille
Journal:  J Rehabil Res Dev       Date:  2014
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.